Status:
COMPLETED
Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni
Lead Sponsor:
Kenya Medical Research Institute
Collaborating Sponsors:
Kanazawa University
Conditions:
Schistosoma Mansoni
Eligibility:
All Genders
6-8 years
Phase:
PHASE2
PHASE3
Brief Summary
Schistosomiasis is classified as among the world's neglected tropical diseases (NTD). Morbidity due to Schistosoma mansoni (S. mansoni) is greatest among school-age children who typically have the hig...
Detailed Description
Background: Schistosomiasis is classified as among the world's neglected tropical diseases (NTD). Morbidity due to Schistosoma mansoni (S.mansoni) is greatest among school-age children who typically h...
Eligibility Criteria
Inclusion
- Consenting parents and guardians
Exclusion
- Children with known allergy to papaya fruit products
Key Trial Info
Start Date :
May 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04679831
Start Date
May 6 2021
End Date
March 30 2022
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mbita
Mbita, Kenya, 40305